Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial-Reference-Cited by-同舟云学术

Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial

Published:2022-12 Issue:12 Volume:21 Page:1099-1109
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Soileau Michael J,Aldred Jason,Budur Kumar,Fisseha Nahome,Fung Victor SC,Jeong Anna,Kimber Thomas E,Klos Kevin,Litvan Irene,O'Neill Daniel,Robieson Weining Z,Spindler Meredith A,Standaert David G,Talapala Saritha,Vaou Eleni Okeanis,Zheng Hui,Facheris Maurizio F,Hauser Robert A

Funder

AbbVie

Publisher

Elsevier BV

Subject

Neurology (clinical)

Reference28 articles.

1. Are dopaminergic neurons selectively vulnerable to Parkinson's disease?;Agid;Adv Neurol,1993

2. Diagnostic criteria for Parkinson disease;Gelb;Arch Neurol,1999

3. Motor and nonmotor complications of levodopa: phenomenology, risk factors, and imaging features;Ray Chaudhuri;Mov Disord,2018

4. Late-stage Parkinson disease;Coelho;Nat Rev Neurol,2012

5. The scientific and clinical basis for the treatment of Parkinson disease (2009);Olanow;Neurology,2009

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical progression of Parkinson’s disease in the early 21st century: Insights from AMP-PD dataset;2024-01-30

2. Stability and Volatility of Human Rest-Activity Rhythms: Insights from Very Long Actograms (VLAs);2024-01-22

3. Medical, surgical, and physical treatments for Parkinson's disease;The Lancet;2024-01

4. Therapieansätze für das fortgeschrittene idiopathische Parkinson-Syndrom;DNP – Die Neurologie & Psychiatrie;2023-12

5. Can Continuous Levodopa Delivery Be Achieved in the Absence of Intrajejunal Levodopa Infusion? Implications for India and Underserved Countries;Movement Disorders Clinical Practice;2023-11-28